3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
5
Melanoma
2
Glioblastoma
2
Brain Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Squamous Cell Carcinoma of Head and Neck
1
Oligodendroglioma
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Lymphoma, Follicular
1
Laryngeal Neoplasms
1
Glioma
1
Ganglioneuroblastoma
1
Craniopharyngioma
1
Carcinoma
1
Astrocytoma
1
Interventions
pembrolizumab
36
Bevacizumab
25
Cyclophosphamide
23
Blood Specimen Collection
19
Nivolumab
17
Standard of Care
15
Carboplatin
15
Paclitaxel
14
atezolizumab
13
Gemcitabine
13
Exercise
13
Pemetrexed
11
Fluorouracil
11
Doxorubicin
11
Cisplatin
11
Cetuximab
10
Radiotherapy
9
Oxaliplatin
9
Magnetic Resonance Spectroscopy
9
Leucovorin
9
Docetaxel
9
130-nm albumin-bound paclitaxel
9
durvalumab
8
abemaciclib
8
Temozolomide
8
Surveys and Questionnaires
8
Rituximab
8
Prednisone
8
Biopsy
8
olaparib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Transurethral Resection of Bladder
×
90 days
×
Clear all
No trials found.